Haleon plc
HLN
Ранг среди акций
#13649
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Цена акции
$5.12
Рыночная капитализация
$450.23M
Изменение (1 день)
-0.40%
Изменение (1 год)
8.68%
Страна
GB
Торговля Haleon plc (HLN)
Категория
Healthcare
Коэффициент P/B для Haleon plc (HLN)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Haleon plc, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Haleon plc с 2026 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | - |
IN
|
